Therapeutic Targeting of the Bcl-6: p53 Axis with Histone Deacetylase Inhibitors in Diffuse Large B-Cell Lymphoma

被引：0
|
作者：
Amengual, Jennifer E. [1 ]
Kalac, Matko [1 ]
Scotto, Luigi [1 ]
Sleckman, Patrick A. [2 ]
Marchi, Enrica [1 ]
Deng, Changchun [1 ]
Bongero, Danielle C. [1 ]
Jain, Salvia [1 ]
Buitrago, Jairo Baquero [1 ]
O'Connor, Owen A. [1 ]
机构：
[1] NYU Langone Med Ctr, NYU Canc Inst, New York, NY USA
[2] Lake Erie Coll Osteopath Med, Erie, PA USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1593 / 1594
页数：2
相关论文
共 50 条
  • [1] BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?
    Dunleavy, Kieron
    Davis, R. Eric
    Landgren, Ola
    Staudt, Louis M.
    Wilson, Wyndham H.
    BLOOD, 2007, 109 (02) : 843 - 844
  • [2] Mechanisms of Sensitivity and Resistance to Histone Deacetylase Inhibitors in Diffuse Large B-Cell Lymphoma
    Tula-Sanchez, Ana A.
    Havas, Aaron
    Alonge, Peter
    Klein, Mary E.
    Rogers, Taralyn Y.
    Szeto, Emily
    Rimsza, Lisa M.
    Smith, Catharine L.
    BLOOD, 2012, 120 (21)
  • [3] The cellular and genomic response to histone deacetylase inhibitors in diffuse large b-cell lymphoma
    Tula-Sanchez, Ana A.
    Klein, Mary E.
    Smith, Catharine L.
    An, Lingling
    CANCER RESEARCH, 2011, 71
  • [4] Emerging role of histone deacetylase inhibitors in the treatment of diffuse large B-cell lymphoma
    Wang, Mingyang
    Fang, Xiaosheng
    Wang, Xin
    LEUKEMIA & LYMPHOMA, 2020, 61 (04) : 763 - 775
  • [5] Bcl-6 gene hypermutations in diffuse large B-cell lymphoma of primary gastric origin
    Liang, R
    Chan, WP
    Kwong, YL
    Chan, ACL
    Xu, WS
    Au, WY
    Srivastava, G
    Ho, FCS
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (03) : 668 - 670
  • [6] BCL-2, BCL-6 AND MYC REARRANGEMENTS AND CLINICAL OUTCOME OF DIFFUSE LARGE B-CELL LYMPHOMA
    Sobas, M. S.
    Tojo, M.
    Tubio, M.
    Fraga, M.
    Bello, J. L.
    Forteza, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 278 - 279
  • [7] Progress in deciphering the role of p53 in diffuse large B-cell lymphoma: mechanisms and therapeutic targets
    Wen, Wen
    Zhang, Wen-Lu
    Tan, Ran
    Zhong, Tan-Tan
    Zhang, Mei-Rui
    Fang, Xiao-Sheng
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (07): : 3280 - 3293
  • [8] Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: Significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma
    Ree, HJ
    Yang, WI
    Kim, CW
    Huh, J
    Lee, SS
    Cho, EY
    Ko, YH
    Charney, D
    HUMAN PATHOLOGY, 2001, 32 (09) : 954 - 962
  • [9] Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma
    Sohn, SK
    Jung, JT
    Kim, DH
    Kim, JG
    Kwak, EK
    Park, TI
    Shin, DG
    Sohn, KR
    Lee, KB
    AMERICAN JOURNAL OF HEMATOLOGY, 2003, 73 (02) : 101 - 107
  • [10] Targeting B-cell lymphoma 6 (BCL6) for the treatment of diffuse large B-cell lymphomas (DLBCLs)
    Cardenas, Mariano
    Yu, Wenbo
    Zhu, Shilei
    Cerchietti, Leandro C.
    Melnick, Ari
    MacKerell, Alexander D., Jr.
    Xue, Fengtian
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
12345